Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
40 participants
OBSERVATIONAL
2020-09-15
2025-11-02
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Identifying New Biomarkers of Parkinson's From Routine Brain Imaging
NCT04986020
Neuromelanin MRI: A Progression Marker in Early PD
NCT05631158
Imaging Blood Brain Imaging Dysfunction in Parkinson's Disease
NCT02605161
Developing a Novel Imaging Biomarker in the Differential Diagnosis of Parkinson's Disease and Parkinsonism
NCT02059733
Magnetic Resonance Imaging Studies of Motor and Thought Processes
NCT00001361
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The study uses magnetic resonance imaging (MRI), a noninvasive imaging technique that does not include X-rays. MRI will assess brain activity in response to simple and coordinated movements of the upper and lower limbs that participants have to perform inside the MRI scanner. Motor and cognitive function outside the scanner using various clinical and behavioral tests will also be assessed. The study includes 1 visit to the University of Delaware.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Parkinson's disease
Individuals with a clinical diagnosis of Parkinson's disease.
No interventions assigned to this group
Healthy
Healthy individuals with no known neurological disorders.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* No neurological disorders if interested in participating as a control participant
* Must be capable of providing informed consent
* Must be eligible to receive a brain MRI
Exclusion Criteria
* Dementia
* Medical conditions that may make one ineligible for receiving a brain MRI
* Inability to provide informed consent
* Control/healthy group: neurological disorders
* Control/healthy group: cannot walk without an assistive device/mobility problems
45 Years
85 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Delaware
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Roxana Burciu
Assistant Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Roxana G Burciu, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Delaware
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Delaware
Newark, Delaware, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1407867
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.